<?xml version="1.0" encoding="UTF-8"?>
<ref id="jca21806-bib-0016">
 <label>16</label>
 <mixed-citation publication-type="miscellaneous" id="jca21806-cit-0016">
  <collab collab-type="authors">FDA</collab> . Investigational covid‐19 convalescent plasma—emergency INDs. 
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines%2010blood%2010biologics/investigational%2010new%2010drug%2010ind%2010or%2010device%2010exemption%2010ideprocess%2010cber/investigational%2010covid%201019%2010convalescent%2010plasma%2010emergency%2010inds" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ideprocess-cber/investigational-covid-19-convalescent-plasma-emergency-inds</ext-link>. Accessed May 11, 
  <year>2020</year>.
 </mixed-citation>
</ref>
